SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-010452
Filing Date
2021-05-05
Accepted
2021-05-04 19:30:53
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 22830
2 ex99-1.htm EX-99.1 296801
3 ex99-2.htm EX-99.2 166968
4 ex99-1_001.jpg GRAPHIC 5349
5 ex99-2_001.jpg GRAPHIC 5349
6 ex99-3.htm EX-99.3 16229
7 ex99-4.htm EX-99.4 16233
  Complete submission text file 0001493152-21-010452.txt   3192056

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE aezs-20210331.xml EX-101.INS 505182
9 XBRL SCHEMA FILE aezs-20210331.xsd EX-101.SCH 58589
10 XBRL CALCULATION FILE aezs-20210331_cal.xml EX-101.CAL 77932
11 XBRL DEFINITION FILE aezs-20210331_def.xml EX-101.DEF 144103
12 XBRL LABEL FILE aezs-20210331_lab.xml EX-101.LAB 322162
13 XBRL PRESENTATION FILE aezs-20210331_pre.xml EX-101.PRE 234818
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 21890556
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences